Seth Klarman · Q4 2014
Baupost Group
Portfolio at the end of Q4 2014, from the 13F filed February 13, 2015. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Cheniere Energy LNG · history | 19.1% | Q1 2014 | Add 23% |
| Viasat VSAT · history | 14.3% | Q2 2013 or earlier | No change |
| Micron Technology MU · history | 13.6% | Q2 2013 or earlier | Reduce 62% |
| eBay EBAY · history | 10.3% | Q2 2014 | Add 53% |
| Antero Resources AR · history | 6.3% | Q3 2014 | Add 184% |
| Innoviva INVA · history | 5.5% | Q2 2013 or earlier | No change |
| Keryx Biopharmaceuticals KERX · history | 5.1% | Q1 2014 | No change |
| PBF Energy PBF · history | 4.5% | Q3 2013 | Add 21% |
| Veritiv VRTV · history | 2.4% | Q3 2014 | Reduce 2% |
| Forward Pharma FWP · history | 2.2% | Q4 2014 | Buy |
| Theravance Biopharma TBPH · history | 1.8% | Q2 2014 | No change |
| Onity Group OCN · history | 1.8% | Q3 2014 | Reduce 15% |
| Citigroup C.WS · warrants · history | 1.8% | Q2 2013 or earlier | Reduce 16% |
| SunEdison Semiconductor SEMI · history | 1.5% | Q2 2014 | No change |
| ChipMOS IMOS · history | 1.5% | Q2 2013 or earlier | No change |
| Bellatrix Exploration BXE · history | 1.3% | Q4 2014 | Buy |
| Novagold Resources NG · history | 1.3% | Q2 2013 or earlier | No change |
| Paratek Pharmaceuticals PRTK · history | 1.2% | Q4 2014 | Buy |
| Kosmos Energy KOS · history | 1.2% | Q2 2014 | Add 52% |
| Atara Biotherapeutics ATRA · history | 1.2% | Q4 2014 | Buy |
| Innoviva INVA.CV · convertible notes · history | 0.6% | Q3 2014 | Add 135% |
| Syneron Medical ELOS · history | 0.4% | Q2 2013 or earlier | Reduce 19% |
| Kindred Biosciences KIN · history | 0.4% | Q4 2013 | No change |
| American International Group AIG.WS · warrants · history | 0.4% | Q2 2013 or earlier | Add 13% |
| Alon USA Partners ALDW · history | 0.2% | Q4 2013 | Add 190% |
| Pyxus International AOI · history | 0.2% | Q2 2013 or earlier | No change |
| Trilogy Metals TMQ · history | 0.1% | Q2 2013 or earlier | No change |
| 27 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q3 2014, adjusted for stock splits.
Sector weighting
| Energy | 32.6% | |
|---|---|---|
| Health care | 18.4% | |
| Technology | 16.6% | |
| Media & telecom | 14.3% | |
| Consumer discretionary | 10.3% | |
| Financials & real estate | 4.0% | |
| Industrials | 2.4% | |
| Materials | 1.3% | |
| Consumer staples | 0.2% |
What changed from Q3 2014
- Buy Forward Pharma FWP 2.2% of the 13F
- Buy Bellatrix Exploration BXE 1.3% of the 13F
- Buy Paratek Pharmaceuticals PRTK 1.2% of the 13F
- Buy Atara Biotherapeutics ATRA 1.2% of the 13F
- Add 23% Cheniere Energy LNG 15.6% → 19.1%
- Add 53% eBay EBAY 6.0% → 10.3%
- Add 184% Antero Resources AR 2.6% → 6.3%
- Add 21% PBF Energy PBF 3.0% → 4.5%
- Add 52% Kosmos Energy KOS 0.8% → 1.2%
- Add 135% Innoviva INVA.CV 0.3% → 0.6%
- Add 13% American International Group AIG.WS 0.3% → 0.4%
- Add 190% Alon USA Partners ALDW 0.1% → 0.2%
- Reduce 62% Micron Technology MU 30.8% → 13.6%
- Reduce 2% Veritiv VRTV 2.1% → 2.4%
- Reduce 15% Onity Group OCN 3.2% → 1.8%
- Reduce 16% Citigroup C.WS 2.0% → 1.8%
- Reduce 19% Syneron Medical ELOS 0.5% → 0.4%
- Sell RF Micro Devices RFMD was 2.0%
- Sell TriQuint Semiconductor TQNT was 2.0%
- Sell Boyd Gaming BYD was 0.2%
- Sell AVEO Oncology AVEO was 0.1%